Literature DB >> 21095582

mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α.

Hakan Cam1, John B Easton, Anthony High, Peter J Houghton.   

Abstract

The mTOR complex-1 (mTORC1) coordinates cell growth and metabolism, acting as a restriction point under stress conditions such as low oxygen tension (hypoxia). Hypoxia suppresses mTORC1 signaling. However, the signals by which hypoxia suppresses mTORC1 are only partially understood, and a direct link between hypoxia-driven physiological stress and the regulation of mTORC1 signaling is unknown. Here we show that hypoxia results in ataxia telangiectasia mutated (ATM)-dependent phosphorylation of hypoxia-inducible factor 1-alpha (HIF-1α) on serine(696) and mediates downregulation of mTORC1 signaling. Deregulation of these pathways in pediatric solid tumor xenografts suggests a link between mTORC1 dysregulation and solid tumor development and points to an important role for hypoxic regulation of mTORC1 activity in tumor development.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21095582      PMCID: PMC3004768          DOI: 10.1016/j.molcel.2010.10.030

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  63 in total

Review 1.  Exploiting tumour hypoxia in cancer treatment.

Authors:  J Martin Brown; William R Wilson
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

Review 2.  Upstream and downstream of mTOR.

Authors:  Nissim Hay; Nahum Sonenberg
Journal:  Genes Dev       Date:  2004-08-15       Impact factor: 11.361

3.  Proteomic studies of the intrinsically unstructured mammalian proteome.

Authors:  Charles A Galea; Vishwajeeth R Pagala; John C Obenauer; Cheon-Gil Park; Clive A Slaughter; Richard W Kriwacki
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

4.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

5.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

Review 6.  Control of the hypoxic response through regulation of mRNA translation.

Authors:  Bradly G Wouters; Twan van den Beucken; Michael G Magagnin; Marianne Koritzinsky; Diane Fels; Constantinos Koumenis
Journal:  Semin Cell Dev Biol       Date:  2005 Aug-Oct       Impact factor: 7.727

7.  A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets.

Authors:  Andrew M Arsham; Jessica J Howell; M Celeste Simon
Journal:  J Biol Chem       Date:  2003-05-30       Impact factor: 5.157

8.  Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.

Authors:  Philippe P Roux; Bryan A Ballif; Rana Anjum; Steven P Gygi; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-01       Impact factor: 11.205

9.  Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53.

Authors:  Chung-Han Lee; Ken Inoki; Magdalena Karbowniczek; Emmanuel Petroulakis; Nahum Sonenberg; Elizabeth Petri Henske; Kun-Liang Guan
Journal:  EMBO J       Date:  2007-10-25       Impact factor: 11.598

Review 10.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression.

Authors:  Diane C Fingar; John Blenis
Journal:  Oncogene       Date:  2004-04-19       Impact factor: 9.867

View more
  114 in total

1.  Underexpression and abnormal localization of ATM products in ataxia telangiectasia patients bearing ATM missense mutations.

Authors:  Virginie Jacquemin; Guillaume Rieunier; Sandrine Jacob; Dorine Bellanger; Catherine Dubois d'Enghien; Anthony Laugé; Dominique Stoppa-Lyonnet; Marc-Henri Stern
Journal:  Eur J Hum Genet       Date:  2011-11-09       Impact factor: 4.246

Review 2.  Regulation of mammalian target of rapamycin complex 1 (mTORC1) by hypoxia: causes and consequences.

Authors:  Hakan Cam; Peter J Houghton
Journal:  Target Oncol       Date:  2011-04-16       Impact factor: 4.493

3.  Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy.

Authors:  Heloisa Veasey Rodrigues; Danxia Ke; JoAnn Lim; Bettzy Stephen; Jorge Bellido; Filip Janku; Ralph Zinner; Apostolia Tsimberidou; David Hong; Sarina Piha-Paul; Siqing Fu; Aung Naing; Vivek Subbiah; Daniel Karp; Gerald Falchook; Razelle Kurzrock; Jennifer Wheler
Journal:  Invest New Drugs       Date:  2015-04-24       Impact factor: 3.850

Review 4.  Challenges and Opportunities for Childhood Cancer Drug Development.

Authors:  Peter J Houghton; Raushan T Kurmasheva
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

Review 5.  ATM protein kinase: the linchpin of cellular defenses to stress.

Authors:  Shahzad Bhatti; Sergei Kozlov; Ammad Ahmad Farooqi; Ali Naqi; Martin Lavin; Kum Kum Khanna
Journal:  Cell Mol Life Sci       Date:  2011-05-02       Impact factor: 9.261

Review 6.  Inside the hypoxic tumour: reprogramming of the DDR and radioresistance.

Authors:  Katheryn Begg; Mahvash Tavassoli
Journal:  Cell Death Discov       Date:  2020-08-18

7.  A compendium of proteins that interact with HIF-1α.

Authors:  Gregg L Semenza
Journal:  Exp Cell Res       Date:  2017-03-20       Impact factor: 3.905

8.  Multiple across-strain and within-strain QTLs suggest highly complex genetic architecture for hypoxia tolerance in channel catfish.

Authors:  Xiaozhu Wang; Shikai Liu; Chen Jiang; Xin Geng; Tao Zhou; Ning Li; Lisui Bao; Yun Li; Jun Yao; Yujia Yang; Xiaoxiao Zhong; Yulin Jin; Rex Dunham; Zhanjiang Liu
Journal:  Mol Genet Genomics       Date:  2016-10-12       Impact factor: 3.291

9.  Hypoxia suppresses conversion from proliferative arrest to cellular senescence.

Authors:  Olga V Leontieva; Venkatesh Natarajan; Zoya N Demidenko; Lyudmila G Burdelya; Andrei V Gudkov; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-30       Impact factor: 11.205

Review 10.  Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions.

Authors:  Mark Ambrose; Richard A Gatti
Journal:  Blood       Date:  2013-02-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.